Cost-utility analysis of antithyroid drug therapy versus 131I therapy for Graves' disease

Kakuigaku

Volumn 42, Issue 2, 2005, Pages 87-95

  Hayashi, Katsumi ^a   Abe, Katsumi ^a   Sakata, Ikuko ^a   Sakaguchi, Chiharu ^a   Yamamoto, Kentaro ^a   Kosuda, Shigera ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Antithyroid drug; Cost benefit analysis; Graves' disease; Radioiodine therapy

Indexed keywords

ANTITHYROID AGENT; RADIOACTIVE IODINE;

ADULT; ARTICLE; COST UTILITY ANALYSIS; DRUG COST; FEMALE; GRAVES DISEASE; HOSPITAL BILLING; HUMAN; JAPAN; QUESTIONNAIRE;

ADULT; ANTITHYROID AGENTS; COHORT STUDIES; COST-BENEFIT ANALYSIS; DRUG UTILIZATION; FEMALE; GRAVES DISEASE; HUMANS; IODINE RADIOISOTOPES; QUESTIONNAIRES; RADIOPHARMACEUTICALS;

EID: 22444442234     PISSN: 00227854     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Chiovato L, Barbesino G, Piochera A. Treatment of Graves' disease. In: DeGroot LJ, Jameson JL, eds., Endocrinology, 4th ed. W.B. Saunders Co., Philadelphia, 2001: 1434-1437.
2. Allahabadia A, Daykin J, Holder RL, Sheppard MC, Gough SCL, Franklyn JA: Age and gender predict the outcome of treatment for Graves' hyperthyroidism. J Clin Endocrinol Metab 2003; 85: 1038-1042.
3. Schipper H, Clinch J, McMurray A, Levitt M: Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. J Clin Oncol 1984; 2: 472-483.
4. 131I therapy for Graves' disease: Case selection and restrictions recommended to patients in Japan, Korea, and China. Thyroid 1997; 7: 217-220.
5. Mori T, Sugawa H, Kosugi S, Ueda M, Hai N, Matsuda A: Recent trends in the management of Graves' hyperthyroidism in Japan: Opinion survey results, especially on the combination therapy of antithyroid drug and thyroid hormone. Endocr J 1997; 44: 509-517.
6. Glinoer D, Hesch D, Lagasse R, Laurberg P: The management of hyperthyroidism due to Graves' disease in Europe in 1986: results of international survey. Acta Endocrinol 1987; 115 (Suppl 285): 1-23.
7. Konno N, Yuri K, Taguchi H, Miura K, Taguchi S, Hagiwara K, et al: Screening for thyroid disorders in an iodine sufficient area with sensitive thyrotropin assays, and serum thyroid autoantibody and urinary iodine determinations. Clin Endocrinol 1993; 38: 273-281.
8. Okamura K, Ueda K, Sone H, Ikenoue H, Hasuo Y, Sato K, et al: A sensitive thyroid stimulating hormone assay for screening of thyroid functional disorder in elderly Japanese. J Am Geriat Soc 1989; 37: 317-322.
9. Vanderlaan WP, Storrie VM: A survey of the factors controlling thyroid function, with especial reference to newer views on antityhyroid substances. Pharmacol Rev 1955; 7: 301-334.
10. Jpn J Clin Pharmacol Ther 1986; 17: 271-272.
11. Cooper DS: Antithyroid drugs for the treatment of hyperthyroidism caused by Graves' disease. Endocrinol Metab Clin North Am 1998; 27: 225-247.